FDA Approved: OMNARIS — Supplemental Application (Covis Pharma US, Inc)

View source ↗

Summary

The FDA approved a supplemental application for Omnaris (ciclesonide) submitted by Covis Pharma US, Inc., authorizing an update to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Omnaris (Ciclesonide)

Snippet

SUPPL AP for OMNARIS (CICLESONIDE)